Defective factor VIII causes hemophilia A
Wei W, Misra S, Cannon MV, Yang R, Zhu X, Gilmore R, Zhu M, Zhang B. Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII. Biochem J. 2018 Mar 06;475(5):873–86. PMID: 29444815; PMCID: PMC5957299.; Wei W, Zheng C, Zhu M, Zhu X, Yang R, Misra S, Zhang B. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII. Scientific Reports. 2017 Mar 22;7(1):45033. doi: 10.1038/srep45033.; Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016 Jul 09;388(10040):187–97. doi: 10.1016/s0140-6736(15)01123-x. PMID: 26897598.; Turner NA, Moake JL. Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings. PLoS ONE. 2015 Oct 16;10(10):e0140740. doi: 10.1371/journal.pone.0140740.; Pahl S, Pavlova A, Driesen J, Oldenburg J. Effect of F8 B domain gene variants on synthesis, secretion, activity and stability of factor VIII protein. Thromb Haemost. 2014 Jan;111(1):58–66. doi: 10.1160/th13-01-0028. PMID: 24108539.; Gilbert GE, Novakovic VA, Kaufman RJ, Miao H, Pipe SW. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity. Blood. 2012 Aug 30;120(9):1923–32. PMID: 22613792; PMCID: PMC3433094.; Shahani T, Lavend'homme R, Luttun A, Saint-Remy JM, Peerlinck K, Jacquemin M. Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool. Blood. 2010 Jun 10;115(23):4902–9. doi: 10.1182/blood-2009-07-232546. PMID: 20351306.; Newell JL, Fay PJ. Cleavage at Arg-1689 Influences Heavy Chain Cleavages during Thrombin-catalyzed Activation of Factor VIII. Journal of Biological Chemistry. 2009 Apr;284(17):11080–9. doi: 10.1074/jbc.m900234200.; Ngo JC, Huang M, Roth DA, Furie BC, Furie B. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure. 2008 Apr;16(4):597–606. doi: 10.1016/j.str.2008.03.001. PMID: 18400180.; Newell JL, Fay PJ. Proteolysis at Arg740 Facilitates Subsequent Bond Cleavages during Thrombin-catalyzed Activation of Factor VIII. Journal of Biological Chemistry. 2007 Aug;282(35):25367–75. doi: 10.1074/jbc.m703433200.; LENTING PJ, VAN SCHOOTEN CJM, DENIS CV. Clearance mechanisms of von Willebrand factor and factor VIII. Journal of Thrombosis and Haemostasis. 2007 Jul;5(7):1353–60. doi: 10.1111/j.1538-7836.2007.02572.x.; Nogami K, Zhou Q, Wakabayashi H, Fay PJ. Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site. Blood. 2005 Jun 01;105(11):4362–8. PMID: 15705787; PMCID: PMC1895030.; Panteleev MA, Saenko EL, Ananyeva NM, Ataullakhanov FI. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa. Biochem J. 2004 Aug 01;381(Pt 3):779–94. PMID: 15104540; PMCID: PMC1133888.; Jacquemin M, De Maeyer M, D'Oiron R, Lavend'Homme R, Peerlinck K, Saint-Remy J. Molecular mechanisms of mild and moderate hemophilia A. Journal of Thrombosis and Haemostasis. 2003 Mar;1(3):456–63. doi: 10.1046/j.1538-7836.2003.00088.x.; Ahmad SS, London FS, Walsh PN. The assembly of the factor X-activating complex on activated human platelets. Journal of Thrombosis and Haemostasis. 2003 Jan;1(1):48–59. doi: 10.1046/j.1538-7836.2003.00020.x.; Hakeos W, Miao H, Sirachainan N, Kemball-Cook G, Saenko E, Kaufman R, Pipe S. Hemophilia A Mutations within the Factor VIII A2-A3 Subunit Interface Destabilize Factor VIIIa and Cause One-stage/ Two-stage Activity Discrepancy. Thromb Haemost. 2002;88(11):781–7. doi: 10.1055/s-0037-1613302.; White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J; Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001 Mar;85(3):560. PMID: 11307831.; Jacquemin M, Lavend'homme R, Benhida A, Vanzieleghem B, d'Oiron R, Lavergne J, Brackmann HH, Schwaab R, VandenDriessche T, Chuah MKL, Hoylaerts M, Gilles JGG, Peerlinck K, Vermylen J, Saint-Remy JR. A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. 2000 Aug 01;96(3):958–65. doi: 10.1182/blood.v96.3.958.015k13_958_965.; Amano K, Sarkar R, Pemberton S, Kemball-Cook G, Kazazian HH, Kaufman RJ. The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII. 1998 Jan 15;91(2):538–48. doi: 10.1182/blood.v91.2.538.538_538_548.; Gilbert GE, Arena AA. Activation of the Factor VIIIa-Factor IXa Enzyme Complex of Blood Coagulation by Membranes Containing Phosphatidyl-L-serine. Journal of Biological Chemistry. 1996 May;271(19):11120–5. doi: 10.1074/jbc.271.19.11120.; Antonarakis SE, Kazazian HH, Tuddenham EG. Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat. 1995;5(1):1–22. doi: 10.1002/humu.1380050102. PMID: 7728145.; Lollar P, Parker ET. Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog. Journal of Biological Chemistry. 1991 Jul;266(19):12481–6. doi: 10.1016/s0021-9258(18)98924-6.; Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. Journal of Biological Chemistry. 1990 Jan;265(3):1688–92. doi: 10.1016/s0021-9258(19)40071-9.; Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985 Oct;317(6039):726–9. doi: 10.1038/317726a0. PMID: 3932885.; Salen P, Babiker HM: Hemophilia A .